INSTARELIEF
DEAD

Serial Number

88810089

Owner

DXM Pharmaceutical, Inc.

Attorney

Keith B. Willhelm

Filing Date

Feb 25, 2020

Add to watchlist:

No watchlists yet
View on USPTO

INSTARELIEF Trademark

Serial Number: 88810089

INSTARELIEF is a trademark filed by DXM Pharmaceutical, Inc. on February 25, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

DXM Pharmaceutical, Inc. (17 trademarks)

2717 Commercial Center Blvd - Suite E200
Katy, TX 77494

Entity Type: 03

Trademark Details

Filing Date

February 25, 2020

Registration Date

Not Registered

Goods & Services

pharmaceutical preparations including over-the-counter drug syrups and other preparations; over-the-counter cough syrups and other preparations for suppressing coughs; over-the-counter energy syrups and other preparations for boosting energy; over-the-counter anti-allergy syrups and other preparations for relieving allergy symptoms; over-the-counter antihistamine syrups and other preparations for relieving allergy symptoms; over-the-counter analgesic syrups and other preparations for relieving pain; over-the-counter expectorant syrups and other preparations for relieving bronchial congestion; over-the-counter anti-flatulence syrups and other preparations for relieving intestinal distress caused by gastro-intestinal gas; over-the-counter decongestant syrups and other preparations for relieving nasal congestion; over-the-counter drug syrups and other preparations for treating symptoms of the common cold and influenza; over-the-counter drug syrups and other preparations containing more than one of the foregoing active ingredients for relieving multiple symptoms; and over-the-counter dietary supplement syrups and other preparations

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Dec 1, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 1, 2020 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 20, 2020 GNRN
NON-FINAL ACTION E-MAILED
May 20, 2020 GNRT
NON-FINAL ACTION WRITTEN
May 20, 2020 CNRT
ASSIGNED TO EXAMINER
May 13, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 28, 2020 NWOS
NEW APPLICATION ENTERED
Feb 28, 2020 NWAP